Author: admin

How Coast Family Home Care’s Caregivers Are Addressing Social Isolation Among Seniors

Coast Family Home Care combats social isolation among seniors through personalized caregiving, fostering emotional support and social engagement to improve seniors’ well-being and quality of life.

Santa Maria, CA – Social isolation among seniors is a growing concern, with studies showing that nearly one in three older adults in the U.S. report feeling lonely or isolated. This issue has been exacerbated by the COVID-19 pandemic, which increased social distancing measures and limited in-person interactions, particularly for older adults. The consequences of isolation include an increased risk of depression, cognitive decline, and a decline in overall health. A report by the National Institute on Aging emphasizes that socially isolated seniors are at a higher risk for conditions such as heart disease, high blood pressure, and even premature death.

In response to these alarming trends, Coast Family Home Care has made it a priority to address social isolation among seniors through their compassionate, personalized caregiving services. The agency’s caregivers not only assist with daily activities but also foster meaningful connections with clients, providing emotional support, companionship, and engagement in social activities. This holistic approach is essential to improving the mental and emotional well-being of seniors.

Coast Family Home Care recognizes the critical need for senior companionship and ensures that caregivers are trained to build trustful relationships with clients. The company also encourages participation in activities like puzzles, games, walks, and virtual connections with family members, which help combat loneliness and provide an avenue for social interaction. These efforts are part of Coast Family Home Care’s broader mission to improve the quality of life for seniors in their own homes, ensuring they remain engaged with their communities and loved ones.

As the demand for home care services continues to grow, Coast Family Home Care is at the forefront of creating solutions that prioritize the social and emotional needs of seniors, ensuring they lead fulfilling and connected lives.

For more information, please visit Coast Family Home Care in Santa Maria.

About Coast Family Home Care:

Coast Family Home Care provides compassionate in-home care services, specializing in supporting seniors with daily activities, companionship, and specialized care plans. Their dedicated team of caregivers ensures that seniors receive high-quality care.

Media Contact
Company Name: Coast Family Home Care
Contact Person: Shirley Minyard
Email: Send Email
Phone: (805) 934-0600
Address:110 N. McClelland street
City: Santa Maria
State: California
Country: United States
Website: https://coastfamilyhomecare.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: How Coast Family Home Care’s Caregivers Are Addressing Social Isolation Among Seniors

Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Metastatic Pancreatic Cancer Pipeline Insight” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It covers the Metastatic Pancreatic Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Metastatic Pancreatic Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Metastatic Pancreatic Cancer pipeline products in this space.

 

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Metastatic Pancreatic Cancer Pipeline Report to explore emerging therapies, key Metastatic Pancreatic Cancer Companies, and future Metastatic Pancreatic Cancer treatment landscapes @ Metastatic Pancreatic Cancer Pipeline Outlook Report

 

Key Takeaways from the Metastatic Pancreatic Cancer Pipeline Report

  • In February 2025:- Erasca Inc.:- This is a Phase 1b/2, open-label, multicenter clinical study evaluating ERAS-007 in combination with other cancer therapies in study participants with GI malignancies. This study will serve as a platform study, allowing for evaluation of safety/tolerability and efficacy of ERAS-007 in combination with other cancer therapies. The study will initially commence with dose escalation of ERAS-007 administered in combination with encorafenib and cetuximab in study participants with metastatic colorectal cancer (CRC) harboring B-Raf proto-oncogene, serine/threonine kinase (BRAF) V600E mutation; and dose escalation of ERAS-007 administered in combination with palbociclib in study participants with metastatic CRC harboring Kirsten rat sarcoma (KRAS) or neuroblastoma rat sarcoma (NRAS) mutations and metastatic pancreatic adenocarcinoma with (PDAC) KRAS mutation.
  • In January 2025:- Shanghai Yizhong Pharmaceutical Co., Ltd.-This trial is a multi-center, randomized, open, parallel-group and positive-controlled phase III trial to evaluate the efficacy and safety of paclitaxel polymeric micelles for injection plus gemcitabine as first-line treatment of metastatic pancreatic cancer compared with nab-Paclitaxel plus gemcitabine.
  • In January 2025: – Verastem Inc.:- This study will assess the safety and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreated.
  • DelveInsight’s Metastatic Pancreatic Cancer pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies for Metastatic Pancreatic Cancer treatment.
  • The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, Chia Tai Tianqing Pharmaceutical Group, Mustang Bio, Novartis, Loxo Oncology, Genmab, Nkarta, Nurix Therapeutics, Prelude Therapeutics and others.
  • Promising Metastatic Pancreatic Cancer Therapies such as Parvovirus H-1 (H-1PV), Sunitinib, Napabucasin, Nab-paclitaxel, Gemcitabine, Dasatinib, mFOLFOX6, and others.

 

Discover how the Metastatic Pancreatic Cancer treatment paradigm is evolving. Access DelveInsight’s in-depth Metastatic Pancreatic Cancer Pipeline Analysis for a closer look at promising breakthroughs @ Metastatic Pancreatic Cancer Clinical Trials and Studies

 

Metastatic Pancreatic Cancer Emerging Drugs Profile

  • Motixafortide: BioLineRx

Motixafortide (formerly known as BL-8040/BKT140) is a novel selective inhibitor of the CXCR4 chemokine receptor. CXCR4, is a well validated therapeutic target that is involved in the mobilization and trafficking of hematopoietic stem cells, immune cells and cancer cells from the bone marrow and the lymph nodes to the peripheral blood. Motixafortide is being developed as a platform for several indications including mobilization of hematopoietic stem cells (HSCs) for autologous transplantations, treatment of solid tumors, and other hematological malignancies.

 

  • Fuzuloparib: Jiangsu Hengrui Pharmaceuticals

Fuzuloparib is a small molecule, orally active PARP inhibitor being developed by Jiangsu Hengrui Pharmaceuticals Co for the treatment of solid cancers. Fuzuloparib has been approved in China for the treatment of ovarian cancer (including fallopian tube cancer or primary peritoneal cancer), and phase II and III trials are investigating fuzuloparib for the treatment of other solid cancers, including cancers of the pancreas, breast, prostate and lungs.

 

  • HP518: Hinova Pharmaceuticals

HP518, a highly selective and orally bioavailable chimeric degrader targeting androgen receptor (AR) with the potential to overcome the drug resistance of prostate cancer due to some specific AR mutations. In discovery and preclinical studies, HP518 showed high degradation activity against wild type AR and some specific AR mutants that are resistant to enzalutamide, and excellent antitumor activity in xenograft mouse models. HP518 is highly selective for AR.

 

The Metastatic Pancreatic Cancer pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Pancreatic Cancer with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Pancreatic Cancer Treatment.
  • Metastatic Pancreatic Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Metastatic Pancreatic Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Pancreatic Cancer market.

 

Get a detailed analysis of the latest innovations in the Metastatic Pancreatic Cancer pipeline. Explore DelveInsight’s expert-driven report today! @ Metastatic Pancreatic Cancer Unmet Needs

 

Metastatic Pancreatic Cancer Companies

Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, Chia Tai Tianqing Pharmaceutical Group, Mustang Bio, Novartis, Loxo Oncology, Genmab, Nkarta, Nurix Therapeutics, Prelude Therapeutics and others.

 

Metastatic Pancreatic Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Intravenous
  • Subcutaneous

 

Metastatic Pancreatic Cancer Products have been categorized under various Molecule types such as

  • Small molecule
  • Cell Therapy
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Download DelveInsight’s latest report to gain strategic insights into upcoming Metastatic Pancreatic Cancer Therapies and key Metastatic Pancreatic Cancer Developments @ Metastatic Pancreatic Cancer Market Drivers and Barriers, and Future Perspectives

 

Scope of the Metastatic Pancreatic Cancer Pipeline Report

  • Coverage- Global
  • Metastatic Pancreatic Cancer Companies-Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, Chia Tai Tianqing Pharmaceutical Group, Mustang Bio, Novartis, Loxo Oncology, Genmab, Nkarta, Nurix Therapeutics, Prelude Therapeutics and others.
  • Promising Metastatic Pancreatic Cancer Therapies– Parvovirus H-1 (H-1PV), Sunitinib, Napabucasin, Nab-paclitaxel, Gemcitabine, Dasatinib, mFOLFOX6, and others.
  • Metastatic Pancreatic Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Metastatic Pancreatic Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Which companies are leading the race in Metastatic Pancreatic Cancer drug development? Find out in DelveInsight’s exclusive Metastatic Pancreatic Cancer Pipeline Report—access it now! @ Metastatic Pancreatic Cancer Emerging Drugs and Major Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Metastatic Pancreatic Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Metastatic Pancreatic Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Rucaparib: Eleison Pharmaceuticals
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. MDB 401 B: Panbela Therapeutics
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. SBP 101: Takeda Oncology
  15. Drug profiles in the detailed report…..
  16. Early Stage Products (Phase I)
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Metastatic Pancreatic Cancer Key Companies
  21. Metastatic Pancreatic Cancer Key Products
  22. Metastatic Pancreatic Cancer- Unmet Needs
  23. Metastatic Pancreatic Cancer- Market Drivers and Barriers
  24. Metastatic Pancreatic Cancer- Future Perspectives and Conclusion
  25. Metastatic Pancreatic Cancer Analyst Views
  26. Metastatic Pancreatic Cancer Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/cart-cell-therapy-competitive-landscape

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Chemotherapy Induced Anemia Drugs Market 2032: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Prevalence, NDA Approvals, Therapies, and Companies by DelveInsight

“Chemotherapy Induced Anemia Drugs Market”
Chemotherapy-Induced Anemia Companies include Astellas, FibroGen, AstraZeneca, Aileron Therapeutics, Zydus Cadila, Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Amgen, Novartis AG, 3SBio Group, Bristol-Myers Squibb, FibroGen, and others.

(Albany, USA) DelveInsight’s “Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Chemotherapy Induced Anemia, historical and forecasted epidemiology as well as the Chemotherapy Induced Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Chemotherapy Induced Anemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Chemotherapy Induced Anemia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Chemotherapy Induced Anemia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Chemotherapy Induced Anemia market.

 

Request for a Free Sample Report @ Chemotherapy Induced Anemia Market Forecast

 

Some facts of the Chemotherapy Induced Anemia Market Report are:

  • According to DelveInsight, Chemotherapy Induced Anemia market size is expected to grow at a decent CAGR by 2032.
  • The Chemotherapy Induced Anemia market size in the seven major markets was over USD 1 billion in 2021.
  • Leading Chemotherapy Induced Anemia companies working in the market are Astellas, FibroGen, AstraZeneca, Aileron Therapeutics, Zydus Cadila, Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Amgen Inc., Novartis AG, 3SBio Group, Bristol-Myers Squibb, FibroGen, and others.
  • Key Chemotherapy Induced Anemia Therapies expected to launch in the market are Roxadustat (FG-4592), ALRN-6924, Desidustat, and many others.
  • In May 2024, Xyphos Biosciences, Inc., a wholly-owned subsidiary of Astellas, and Poseida Therapeutics, Inc., a publicly traded company, announced that they have formed a research collaboration and license agreement to create new convertible car programs. This will be achieved by combining the cutting-edge cell therapy platforms of both companies.
  • In March 2024, Elsevier, a world leader in providing information solutions and products for science, technology, and medicine, is pleased to announce the launch of a new open-access journal, CMI Communications, in collaboration with ESCMID, the leading European society for clinical microbiology and infectious diseases.
  • On June 2023, Fibrogen announced results of a Randomized, Open-label, Active-controlled, Multicenter Phase 3 Study to Investigate the Efficacy and Safety of Roxadustat for Treatment of Anemia in Subjects Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

 

Chemotherapy Induced Anemia Overview

Chemotherapy-induced anemia (CIA) is a common complication of cancer treatment characterized by a decrease in red blood cell count and hemoglobin levels due to the cytotoxic effects of chemotherapy drugs on bone marrow function. Chemotherapy agents can suppress the production of red blood cells, leading to anemia, which can exacerbate symptoms and decrease quality of life in cancer patients.

The development of Chemotherapy-induced anemia depends on various factors, including the type and dose of chemotherapy drugs, the duration of treatment, the patient’s underlying health status, and the presence of other comorbidities. Symptoms of Chemotherapy-induced anemia may include fatigue, weakness, shortness of breath, dizziness, pale skin, and increased heart rate.

Managing Chemotherapy-induced anemia involves a multifaceted approach aimed at alleviating symptoms, improving hemoglobin levels, and maintaining quality of life for cancer patients. Treatment options may include red blood cell transfusions to quickly replenish hemoglobin levels, erythropoiesis-stimulating agents (ESAs) to stimulate red blood cell production, and iron supplementation to address underlying iron deficiency.

Additionally, supportive care measures such as optimizing nutritional status, managing comorbid conditions, and addressing any underlying causes of anemia are essential components of Chemotherapy-induced anemia management. Close monitoring of hemoglobin levels and symptoms, along with regular communication between healthcare providers and patients, is crucial to ensuring timely intervention and effective management of Chemotherapy-induced anemia during cancer treatment.

 

Do you know what will be the Chemotherapy Induced Anemia market share in 7MM by 2032 @ https://www.delveinsight.com/sample-request/chemotherapy-induced-anemia-market

 

Chemotherapy Induced Anemia Market

The Chemotherapy Induced Anemia market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Chemotherapy Induced Anemia market trends by analyzing the impact of current Chemotherapy Induced Anemia therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Chemotherapy Induced Anemia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Chemotherapy Induced Anemia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Chemotherapy Induced Anemia market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Chemotherapy Induced Anemia Epidemiology

The Chemotherapy Induced Anemia epidemiology section provides insights into the historical and current Chemotherapy Induced Anemia patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Chemotherapy Induced Anemia market report also provides the diagnosed patient pool, trends, and assumptions.

 

Interested to know how the emerging diagnostic approaches will be contributing in increased Chemotherapy Induced Anemia diagnosed prevalence pool? Download report @ Chemotherapy Induced Anemia prevalence

 

Chemotherapy Induced Anemia Drugs Uptake

This section focuses on the uptake rate of the potential Chemotherapy Induced Anemia drugs recently launched in the Chemotherapy Induced Anemia market or expected to be launched in 2019-2032. The analysis covers the Chemotherapy Induced Anemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Chemotherapy Induced Anemia Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Chemotherapy Induced Anemia market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Chemotherapy Induced Anemia Pipeline Development Activities

The Chemotherapy Induced Anemia report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Chemotherapy Induced Anemia key players involved in developing targeted therapeutics.

 

Download report to know which TOP 3 therapies will be capturing the largest Chemotherapy Induced Anemia market share by 2032? Click here @ https://www.delveinsight.com/sample-request/chemotherapy-induced-anemia-market

 

Chemotherapy Induced Anemia Therapeutics Assessment

Major key companies are working proactively in the Chemotherapy Induced Anemia Therapeutics market to develop novel therapies which will drive the Chemotherapy Induced Anemia treatment markets in the upcoming years are Astellas, FibroGen, AstraZeneca, Aileron Therapeutics, Zydus Cadila, Pfizer Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Amgen Inc., Novartis AG, 3SBio Group, Bristol-Myers Squibb, FibroGen, and others.

 

Download sample report @ Chemotherapy Induced Anemia Clinical Trials

 

Chemotherapy Induced Anemia Report Key Insights

1. Chemotherapy Induced Anemia Patient Population

2. Chemotherapy Induced Anemia Market Size and Trends

3. Key Cross Competition in the Chemotherapy Induced Anemia Market

4. Chemotherapy Induced Anemia Market Dynamics (Key Drivers and Barriers)

5. Chemotherapy Induced Anemia Market Opportunities

6. Chemotherapy Induced Anemia Therapeutic Approaches

7. Chemotherapy Induced Anemia Pipeline Analysis

8. Chemotherapy Induced Anemia Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Chemotherapy Induced Anemia Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Chemotherapy Induced Anemia Competitive Intelligence Analysis

4. Chemotherapy Induced Anemia Market Overview at a Glance

5. Chemotherapy Induced Anemia Disease Background and Overview

6. Chemotherapy Induced Anemia Patient Journey

7. Chemotherapy Induced Anemia Epidemiology and Patient Population

8. Chemotherapy Induced Anemia Treatment Algorithm, Current Treatment, and Medical Practices

9. Chemotherapy Induced Anemia Unmet Needs

10. Key Endpoints of Chemotherapy Induced Anemia Treatment

11. Chemotherapy Induced Anemia Marketed Products

12. Chemotherapy Induced Anemia Emerging Therapies

13. Chemotherapy Induced Anemia Seven Major Market Analysis

14. Attribute Analysis

15. Chemotherapy Induced Anemia Market Outlook (7 major markets)

16. Chemotherapy Induced Anemia Access and Reimbursement Overview

17. KOL Views on the Chemotherapy Induced Anemia Market

18. Chemotherapy Induced Anemia Market Drivers

19. Chemotherapy Induced Anemia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/market-assessment-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chemotherapy Induced Anemia Drugs Market 2032: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Prevalence, NDA Approvals, Therapies, and Companies by DelveInsight

Dee Sanders Photography: Capturing Moments, Creating Magic

Montgomery, AL – In the dynamic world of visual storytelling, Dee Sanders Photography has emerged as a beacon of excellence, transforming the way businesses and individuals showcase their stories through captivating imagery. From stunning real estate visuals to heartwarming event captures, this versatile photography studio has become the go-to choice for those seeking to elevate their visual narrative.

Revolutionizing Real Estate Marketing

Dee Sanders Photography has redefined real estate marketing with its innovative approach. The team’s expertise in virtual staging and immersive 3D tours has helped properties sell faster and at better prices. “Dee’s photos made our listing stand out. We had multiple offers within days!” exclaimed Sarah Johnson, a local realtor. The company’s use of drone technology for aerial shots has also been a game-changer, offering potential buyers a comprehensive view of properties and their surroundings.

Immortalizing Life’s Precious Moments

When it comes to event photography, Dee Sanders and his team have an uncanny ability to capture the essence of any occasion. From weddings to corporate gatherings, their unobtrusive yet meticulous approach ensures that no special moment goes unrecorded[3]. “Dee’s team was like invisible ninjas at our wedding. The photos they delivered were beyond our wildest dreams!” shared newlyweds Mark and Emily Thompson.

Empowering Professionals with Striking Portraits

In the corporate world, first impressions matter. Dee Sanders Photography’s professional headshot services have helped countless individuals and organizations put their best face forward[6]. The team’s attention to detail and ability to capture personality in each shot has earned them a loyal following among professionals and institutions alike.

Telling Stories That Move and Inspire

Dee Sanders Photography’s documentary work has garnered praise for its ability to weave compelling narratives through visual storytelling. Their recent project documenting local artisans received critical acclaim, with one critic noting, “Dee’s lens doesn’t just capture images; it captures souls.”

Commercial Photography That Sells

From sleek office spaces to mouth-watering dishes, Dee Sanders Photography’s commercial work has helped businesses showcase their products and services in the best light. “Since updating our website with Dee’s photos, our online bookings have increased by 30%,” reported local restaurant owner, Michael Chen [8].

The Dee Sanders Difference

What sets Dee Sanders Photography apart is not just their technical prowess but their commitment to customer satisfaction. Clients rave about the team’s professionalism, creativity, and ability to deliver beyond expectations [6]. “Working with Dee is like having a mind reader behind the camera. He just gets it,” said long-time client and event planner, Lisa Martinez.

As Dee Sanders Photography continues to push the boundaries of visual storytelling, one thing remains clear: their passion for capturing life’s moments, big and small, is unmatched. Whether you’re selling a home, planning an event, or looking to enhance your brand’s visual appeal, Dee Sanders Photography is ready to turn your vision into stunning reality.

For more information or to book a session, visit www.deesandersphotography.com or call 334-414-3462. Follow Dee Sanders Photography on Facebook, Instagram, and TikTok for daily doses of visual inspiration. You can also reach us at dee@deesmithphotography.com

Media Contact
Company Name: Dee Sanders Photography
Contact Person: Dee Sanders
Email: Send Email
Country: United States
Website: http://www.deesandersphotography.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dee Sanders Photography: Capturing Moments, Creating Magic

TR CHEN ft. Wendyz Zheng Unveil Groundbreaking New Single “Whisper of Spring” – A Mesmerizing Blend of Traditional Chinese Music and Modern R&B; A New Era of Music Videos with VIVO

This spring, international music sensation TR CHEN collaborates with renowned singer-songwriter Wendyz Zheng to release a musical masterpiece that transcends cultural and musical boundaries. The highly anticipated single, “Whisper of Spring”, is now available worldwide on all major streaming platforms, bringing a refreshing wave of Guochao (National Trend) music to a global audience.

“Whisper of Spring” masterfully blends the poetic charm of Lingnan culture, the elegance of traditional Chinese instruments like the pipa and erhu, and contemporary R&B rhythms, creating a unique musical experience that captivates listeners. Sung in Cantonese, the song preserves the beauty of regional dialects while delivering a modern sound with global appeal.

This release marks a significant addition to the “TR CHEN Wave” series, known for its innovative fusion of Eastern and Western musical elements. The series has been celebrated for its creative approach to music, seamlessly integrating traditional Chinese sounds with modern genres.

The Visionary Behind “Whisper of Spring”

TR CHEN—a Malaysian-Thai singer-songwriter, actor, and cultural ambassador—continues to redefine the music scene with his distinctive sound. As a multicultural artist, TR CHEN brings a unique perspective to Cantonese pop music, reflecting his diverse heritage. In “Whisper of Spring”, he not only performs but also takes on the roles of composer and producer, showcasing his multifaceted talent.

TR CHEN’s journey to stardom has been marked by numerous achievements, including: CCTV’s Moving China 2024 Variety Show: Winner of three prestigious awards, including Top 10 Music Composers (4th Place), New Pioneer in Lyric and Composition, and Outstanding Actor Award, 2024 Chinese Mandarin Golden Melody Awards: Winner of Best Film and Television Song of the Year, MMIA Malaysia Most Influential Celebrity Award.

His previous works, including the “Homecoming Trilogy” (Home for New Year, Home for Reunion, Homeward), “Glazed Starry Sky”, “Riding the Wind”, and “Emotional Life” (featured in a Tencent web drama), have resonated deeply with audiences, earning him widespread acclaim and numerous awards.

To bring “Whisper of Spring” to life, TR CHEN collaborated with an exceptional team of prominent musicians from the Greater Bay Area (GBA), creating a masterpiece that bridges cultures and generations.

Joining TR CHEN is Wendyz Zheng, a celebrated singer-songwriter born into a musical family in Toronto, Canada. Known for her soulful voice and emotional storytelling, Wendyz has an impressive portfolio of hit songs across Asia

As a respected songwriter, Wendyz also contributed lyrics to Sammi Cheng’s “Water Dance” theme song and served as the designated backup singer for Sammi Cheng’s world tours. Notably, she penned the Chinese lyrics for “Love of My Life” for Stephen Chow’s film Journey to the West: Conquering the Demons, performed by Shu Qi.

The evocative lyrics of “Whisper of Spring” were crafted by Qu Yao, an emerging lyricist from Macau. Qu Yao gained recognition after winning First Prize at the Guangdong-Hong Kong-Macao Pop Music Songwriting Competition. His notable works include “Lover’s Road” by Yan Mingxi.

The song’s captivating arrangement is by LISTEN, a rising music producer and arranger known for his work on major Chinese television soundtracks and OSTs.

Damon Chui, a renowned Hong Kong composer and producer, lent his expertise in programming and production. His iconic work includes “The Harder It Gets, The More I Love” from the TVB drama Line Walker.

Serving as the Executive Producer, Cui Shi Xuan is a veteran music director and lyricist famous for his OSTs, including “Beauty’s Tribulation”, the opening theme of the legendary drama Empresses in the Palace. Yang Wenbo, an international music producer and DJ, showcases his rap talents, adding a modern flair to the track.

Backing vocals were performed by Wendyz, Zhi Quan, and Wen Bo, three celebrated musicians from the GBA. The intricate harmonies and live instrumentation—including pipa, erhu, and dual guitars—were recorded by a seasoned production team in the GBA.

The music video (MV) for “Whisper of Spring” is a visual masterpiece directed by acclaimed Chinese documentary filmmaker Shi Jianwei. The MV beautifully showcases the cultural heritage and friendship between China and Malaysia, with stunning scenes shot in Zhuhai, Hengqin, Foshan, Taishan, and various locations in Malaysia.

In a groundbreaking move, TR CHEN collaborated with VIVO, one of the world’s top smartphone brands, to film the MV using the VIVO X200 Pro Co-engineered with ZEISS. This innovative approach marks the first time the ZEISS lens technology was used to capture cinematic visuals of traditional Lingnan culture and Malaysian heritage.

“Whisper of Spring” is now available on all major streaming platforms worldwide. This powerful fusion of Cantonese tradition and modern R&B showcases the innovative spirit of the “TR CHEN Wave” and is set to captivate audiences around the world.

“Whisper of Spring” is a poetic celebration of renewal, love, and togetherness, drawing vivid imagery from the blooming beauty of spring. The lyrics paint a picturesque landscape, blending traditional Chinese cultural elements with universal emotions of hope, joy, and reunion. “Whisper of Spring” is a lyrical masterpiece that beautifully blends Cantonese poetry with modern R&B influences. It evokes a sense of nostalgia and hope, celebrating spring as a symbol of renewal, love, and family reunions. Through rich imagery and heartfelt expressions, the song not only resonates with cultural significance but also carries universal emotions of joy and belonging.

Media Contact
Company Name: Happy Media Pro Artists
Contact Person: Kanely R.
Email: Send Email
Country: HongKong
Website: https://happymediapro.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: TR CHEN ft. Wendyz Zheng Unveil Groundbreaking New Single “Whisper of Spring” – A Mesmerizing Blend of Traditional Chinese Music and Modern R&B; A New Era of Music Videos with VIVO

iGulu Expands Its Smart Brewing Ecosystem: From Beer to Health Beverages, Revolutionizing Home Brewing in 2025

iGulu expands beyond beer in 2025, introducing health-focused beverages like kombucha and cider with new S1 model, Brew Kits, and biotech collaborations, targeting beer lovers and health enthusiasts alike.

In a strategic expansion that underscores its commitment to innovation, iGulu is set to redefine home brewing in 2025. Building on the success of its F1 smart brewing machine, launched in 2024, the company introduced the S1 model this January, further solidifying its position as a leader in the smart brewing industry. Alongside these hardware advancements, iGulu is leveraging its Brew Kits and software upgrades to extend fermentation capabilities, transitioning from a beer-focused brand to a comprehensive player in the health beverage market.

From Beer to Health: A New Frontier in Home Brewing

Since its debut, iGulu has been synonymous with accessible, high-quality beer brewing at home. The F1 model, launched in 2024, was a game-changer, offering beer enthusiasts an easy way to craft their favorite brews. Now, with the introduction of more brew kits in 2025, iGulu is taking a significant step forward. The F1/S1 adding enhanced functionality and versatility to support a wider range of fermented beverages.

But iGulu’s evolution doesn’t stop at hardware. Through innovative Brew Kits and continuous software updates, the company is expanding its fermentation capabilities to include:

  • Kombucha: Rich in probiotics, promoting gut health;
  • Hard Cider: A crisp, refreshing alternative to beer;
  • Sparkling White Wine: Elegant and celebratory;
  • Carbonated Drinks: Alcohol-free options for all ages;

This shift reflects iGulu’s response to growing consumer demand for health-conscious, functional beverages. By 2025, iGulu is no longer just a beer-brewing company—it’s a holistic provider of smart fermentation solutions for a healthier lifestyle.

Collaborating with Biotech Leaders for Innovative Health Beverages

In a groundbreaking move, iGulu has partnered with leading North American biotech researchers to develop advanced kombucha formulas. These new recipes are designed to go beyond traditional kombucha, incorporating scientifically-backed ingredients that support gut health and even help lower resting heart rates. This collaboration highlights iGulu’s dedication to merging cutting-edge science with the art of fermentation, offering consumers beverages that are both delicious and beneficial.

Targeting a Diverse Audience: Beer Lovers, Health Enthusiasts, and Fitness Buffs

iGulu’s expanded product line is designed to appeal to a broad spectrum of consumers:

  • Beer Enthusiasts: Who continue to enjoy iGulu’s flagship beer-brewing capabilities;
  • Health-Conscious Consumers: Seeking probiotic-rich, low-sugar beverages like kombucha;
  • Fitness Enthusiasts: Looking for functional drinks that complement their active lifestyles.

By catering to these diverse groups, iGulu is positioning itself as a lifestyle brand that aligns with the values of modern consumers—convenience, health, and sustainability.

A Vision for the Future

“Our goal has always been to make brewing accessible and enjoyable for everyone,” said David Zhang, CEO of iGulu. “With the F1/S1, our expanded Brew Kits, and software upgrades, we’re not just helping people brew beer—we’re empowering them to create a wide variety of beverages that promote health, happiness, and connection.”

As iGulu continues to innovate, it is clear that the company is not just keeping pace with the evolving beverage industry—it is leading the charge. By blending technology, science, and a passion for fermentation, iGulu is redefining what it means to be a home brewer in the 21st century.

For more information, visit our website at iGulu’s website or follow us on Facebook for the latest updates.

About iGulu

iGulu is a leading innovator in smart home brewing technology, dedicated to bringing the craft beverage experience into households worldwide. With a focus on simplicity, quality, and innovation, iGulu is transforming the way people think about brewing, one drink at a time.

Video Link: https://www.youtube.com/embed/YN5TsOToOBg

Media Contact
Company Name: AIBrew Corp
Contact Person: Shu Zhang
Email: Send Email
Phone: 9297197186
City: City of Industry
State: California
Country: United States
Website: www.igulu.com

New Book “From Zero to Six Figures” Empowers Lawyers to Build Thriving Law Firms from Scratch

“Whether you’re a newly licensed attorney or an experienced lawyer looking for a fresh start, From Zero to Six Figures will equip you with the knowledge, tools, and confidence to take control of your legal career and achieve financial success in the industry.”
“From Zero to Six Figures” by Candice E. Iheme Launched to Rave Reviews

Aspiring and seasoned attorneys alike now have the ultimate roadmap to launching and scaling a successful law firm with the release of From Zero to Six Figures, written by legal entrepreneur Candice E. Iheme. Launch on January 31, 2025, this game-changing book provides practical, step-by-step strategies for attorneys looking to break free from traditional firms and build a thriving, six-figure practice—starting from scratch. “Many lawyers dream of opening their firm but hesitate due to uncertainty and lack of guidance,” says Iheme, a practicing attorney who built her law firm from the ground up. “This book is the blueprint I wish I had when I started—a real-world guide to navigating the legal industry as a business owner, not just a practitioner.”

What Readers Will Discover in From Zero to Six Figures

  • How to confidently launch a law firm—even with zero clients.
  • Proven marketing and branding strategies to attract paying clients.
  • Essential systems and tools to run a profitable and efficient practice.
  • Financial management tips to grow a six-figure firm.
  • The biggest mistakes new law firm owners make—and how to avoid them.

Whether you’re a newly licensed attorney or an experienced lawyer looking for a fresh start, From Zero to Six Figures will equip you with the knowledge, tools, and confidence to take control of your legal career and achieve financial success in the industry.

What Readers Are Saying

“A must-read for any lawyer dreaming of independence! Candice E. Iheme delivers a clear, practical roadmap to launching a successful law firm, packed with real-world insights and actionable steps.”

“From Zero to Six Figures is the ultimate guide for lawyers ready to take control of their careers. Iheme’s advice is invaluable, empowering, and straight to the point—highly recommended!”

“An inspiring and practical book that every aspiring law firm owner needs. Iheme breaks down the business side of the law with clarity and confidence, making success feel attainable!”

About the Author

Candice E. Iheme, Esq. is a first-generation American who never initially planned to attend law school. In 2015, while in college, she began working for a Fortune 500 insurance company and quickly became fascinated by the insurance industry. She went on to graduate cum laude from Rutgers University-New Brunswick with a Bachelor’s degree in Economics and a minor in Psychology.

After college, she was offered a full-time position with the same Fortune 500 insurance company. As her experience with clients grew, she noticed a troubling trend—many people had no idea what insurance benefits they were entitled to. This realization inspired her to attend law school so she could advocate for those who could not properly advocate for themselves. Today, she is a successful attorney and entrepreneur dedicated to helping others build sustainable and profitable law firms.

Availability

From Zero to Six Figures is available in paperback and eBook formats on Amazon and major online retailers starting January 31, 2025.

For interviews, speaking engagements, or bulk orders, please get in touch with Candice E. Iheme at Candice@ihemelegal.com or call 551-309-2339.

Follow Candice E. Iheme on Instagram: @candicetheeesquire

Visit IhemeLegal.com for more details.

Media Contact:

Contact: Candice E. Iheme

Email: Candice@ihemelegal.com

Phone: 551-309-2339 W

ebsite: IhemeLegal.com

Instagram: @candicetheeesquire

Media Contact
Company Name: Candice E. Iheme
Contact Person: Candice E. Iheme
Email: Send Email
Country: United States
Website: http://ihemelegal.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Book “From Zero to Six Figures” Empowers Lawyers to Build Thriving Law Firms from Scratch

Foreigners race to Turkey for real estate in İzmir

İzmir along with Çeşme are at the forefront of such interest. Over the last couple of years, Turkey has become a real estate hot spot for foreigners, among which İzmir and the seafront location of Çeşme have come into the limelight. Appealing climate, beautiful natural landscapes, rich cultural heritage, and an attractive Citizenship by Investment program make Turkey very alluring for buyers from Europe and elsewhere.

Izmir: Where Modernity Blends Perfectly with Nature

The Pearl of the Aegean-İzmir boasts modern comfort blended with virgin nature. It is the third biggest city in Turkey and presents a very cosmopolitan lifestyle, which may rival that of Istanbul in a more laid-back and inviting environment. With a well-developed infrastructure, dynamic cultural scene, and proximity to beaches, İzmir can provide an enhanced quality of life for those looking at it.

“İzmir offers everything one would expect from a major city,” says www.davidmelisse.com founder of www.aegeanlocations.com one of the area’s most popular real estate consultancies. “It successfully blends modernity with nature, while being an hour’s drive away from the coastal paradise that is Çeşme. Lots of Europeans are buying second homes here and some have opted to reside year-round.”

Çeşme: A Coastal Paradise

Çeşme is but a short drive from İzmir and is really a treasure along the Turkish coastline. It is known for its crystal-clear waters, quaint villages, and luxury resorts, making it a favorite among those seeking tranquility with class. The area has gained considerable interest from holiday homebuyers, especially from Europe, who are attracted by its relaxed vibe and extraordinary beauty.

Citizenship by Investment in Turkey: A Major Draw

The Citizenship by Investment program in Turkey fuels the real estate boom. Foreign investors get Turkish citizenship, allowing them to travel visa-free to many countries and reside in Turkey in exchange for investing in property worth at least $400,000.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Aegean Locations
Contact Person: David Melisse
Email: Send Email
Phone: +90 553 686 1196
Country: Turkey
Website: http://www.aegeanlocations.com/

Portland Escape Room Hour To Midnight Featured on KGW8’s Hello, Rose City!

Portland Escape Room Hour To Midnight Featured on KGW8’s Hello, Rose City!
In the recent segment, Hour To Midnight owners Ed Wolf and Thomas Johnson sat down to discuss the facility’s newest escape room and the Portland Trail Blazer’s visit

Ed Wolf and Thomas Johnson, co-owners of the Portland, Oregon, premier escape room facility Hour To Midnight, were featured on KGW8’s Hello, Rose City! on January 16, 2025. In the recent segment, Wolf and Johnson gave a glimpse inside their highly rated escape room facility, discussed their newest escape room, and answered burning questions.

Hour To Midnight has become a Portland, Oregon, staple for fun, exciting, and even scary adventures. Within its walls, guests find five daring escape rooms to choose from: The Pharoah’s Lost Relic, The Assassin’s Deadly Game, The Secrets of Nibiru, House of Darkness, and the newest release, Crypt of Shadows. In Crypt of Shadows, players become monster hunters as members of the Nox Venatores. In the storyline, players discover the demise of Arthur Holmwood and then set out to find the most powerful vampire to ever exist, Victor Bathory. This 60-minute escape room is designed for 4-6 players ages 16+ and is ideal for horror fans who want to get their adrenaline rushing.

“The room creators pay attention to detail and have a flare for the theatrical,” said a recent reviewer. “Each room is well planned, and no two rooms feel the same. There are plenty of puzzles to solve in each scenario, making the rooms both challenging and engaging for everyone.”

On Hello, Rose City!, Wolf and Johnson were asked to explain what an escape room is for viewers who might not be familiar with the premise. “You show up and are introduced to a storyline, and then you have a set time limit to work through puzzles and clues,” said the team.

According to them, escape rooms are ideal for work events, birthdays, and team building activities, as evidenced by a recent visit from the Portland Trail Blazers. The team enjoyed working together and, according to Wolf and Johnson, you could tell they were a cohesive team by how they collaborated.

In the segment, viewers got to see an inside view of a few of the facility’s rooms, complete with props fit for a movie set. When players come to Hour To Midnight, they become immersed in a game that feels very real. With a handful of non-scary escape rooms and two horror rooms, there’s truly something for everyone at Hour To Midnight.

Wolf and Johnson thank KGW8 for having them on. See the full segment on the KGW8 website, and learn more about Hour To Midnight by visiting www.hourtomidnight.com.

ABOUT HOUR TO MIDNIGHT

Hour To Midnight is Portland’s premier escape room facility, offering five themed rooms to choose from. Players have 60 minutes to work together to plan their escape. Can you make it? Book now by visiting https://www.hourtomidnight.com/.

Media Contact
Company Name: Hour to Midnight – Escape Rooms Portland
Contact Person: Ed Wolf
Email: Send Email
Phone: (503) 673-3948
Address:11525 NE Halsey St
City: Portland
State: OR
Country: United States
Website: https://www.hourtomidnight.com/

Charlotte Fonne Unveils Breathtaking Landscape Photography Collection

Acclaimed fine art photographer Charlotte Fonne has launched an extraordinary Landscape Collection, offering collectors and art enthusiasts an exclusive opportunity to buy fine art travel photos that capture the beauty of the natural world.

Acclaimed fine art photographer Charlotte Fonne has launched an extraordinary Landscape Collection, offering collectors and art enthusiasts an exclusive opportunity to buy fine art travel photos that capture the beauty of the natural world. The collection, available at CharlotteFonne.com, showcases landscape art photography that transforms fleeting moments into timeless works of art.

This curated series features fine art landscape photography prints for sale, depicting breathtaking vistas from around the globe. Each piece embodies Fonné’s signature style—balancing light, texture, and emotion to create landscape photo prints that transport viewers to some of the most awe-inspiring locations on Earth. With a dedication to artistic excellence, her work is sought after by collectors looking to buy landscape photography that resonates with elegance and authenticity.

“Photography is about capturing the soul of a place,” said Charlotte Fonne. “My landscape photography prints for sale are designed to evoke a sense of wonder, serenity, and connection to nature, turning walls into windows to the world.”

Each art landscape photography print is available in multiple sizes and finishes, ensuring that collectors can find the perfect piece to complement their space. The collection is an invitation to own a slice of nature’s beauty through fine art landscape photography that stands the test of time.

For more information or to explore the collection, visit CharlotteFonne.com.

About Charlotte Fonne

Charlotte Fonné is an internationally recognized fine art photographer specializing in travel and landscape art photography. With a keen eye for composition and storytelling, her work has been featured in galleries and private collections worldwide.

Media Contact
Company Name: Charlotte Fonne Art
Contact Person: Charlotte Fonne
Email: Send Email
City: Miami
State: Florida
Country: United States
Website: https://charlottefonne.com/pages/printshop